Merck, Endocyte Halt Study of Ovarian Cancer Treatment

Merck & Co. and Endocyte Inc. said they stopped a late-stage study of an ovarian-cancer treatment because results fell short of its goal.



from WSJ.com: US Business http://ift.tt/1lGZIsR

via IFTTT